Free Trial

Pheton (PTHL) Competitors

Pheton logo
$20.94 +0.33 (+1.60%)
Closing price 04:00 PM Eastern
Extended Trading
$21.24 +0.30 (+1.45%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PTHL vs. AXGN, BFLY, SMLR, DCTH, TMCI, OM, NPCE, CLPT, NNOX, and SKIN

Should you be buying Pheton stock or one of its competitors? The main competitors of Pheton include AxoGen (AXGN), Butterfly Network (BFLY), Semler Scientific (SMLR), Delcath Systems (DCTH), Treace Medical Concepts (TMCI), Outset Medical (OM), NeuroPace (NPCE), ClearPoint Neuro (CLPT), Nano-X Imaging (NNOX), and Beauty Health (SKIN). These companies are all part of the "medical equipment" industry.

Pheton vs. Its Competitors

Pheton (NASDAQ:PTHL) and AxoGen (NASDAQ:AXGN) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability, media sentiment and risk.

AxoGen has a consensus target price of $24.50, suggesting a potential upside of 107.28%. Given AxoGen's stronger consensus rating and higher possible upside, analysts plainly believe AxoGen is more favorable than Pheton.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pheton
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
AxoGen
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00

Pheton has a net margin of 0.00% compared to AxoGen's net margin of -3.68%. Pheton's return on equity of 0.00% beat AxoGen's return on equity.

Company Net Margins Return on Equity Return on Assets
PhetonN/A N/A N/A
AxoGen -3.68%-7.09%-3.67%

Pheton has higher earnings, but lower revenue than AxoGen.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pheton$450K306.19-$660KN/AN/A
AxoGen$187.34M2.87-$9.96M-$0.15-78.80

In the previous week, Pheton had 1 more articles in the media than AxoGen. MarketBeat recorded 4 mentions for Pheton and 3 mentions for AxoGen. AxoGen's average media sentiment score of 1.19 beat Pheton's score of 0.47 indicating that AxoGen is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Pheton
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
AxoGen
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

80.3% of AxoGen shares are held by institutional investors. 2.8% of AxoGen shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

AxoGen beats Pheton on 7 of the 13 factors compared between the two stocks.

Get Pheton News Delivered to You Automatically

Sign up to receive the latest news and ratings for PTHL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PTHL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PTHL vs. The Competition

MetricPhetonMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$135.65M$7.17B$5.57B$9.31B
Dividend YieldN/A2.86%4.23%4.03%
P/E RatioN/A34.3928.6119.73
Price / Sales306.1936.67412.31173.11
Price / CashN/A25.1136.0257.96
Price / Book22.288.218.235.67
Net Income-$660K$236.06M$3.23B$257.79M
7 Day Performance4.75%-2.05%-0.01%0.52%
1 Month Performance17.84%0.95%5.61%8.84%
1 Year PerformanceN/A18.91%26.52%14.18%

Pheton Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PTHL
Pheton
N/A$20.94
+1.6%
N/AN/A$135.65M$450K0.0011High Trading Volume
AXGN
AxoGen
2.3016 of 5 stars
$11.36
+3.9%
$24.50
+115.7%
+34.8%$497.80M$187.34M-75.73450News Coverage
Positive News
Analyst Revision
High Trading Volume
BFLY
Butterfly Network
2.5468 of 5 stars
$1.89
-2.6%
$3.50
+85.2%
+47.5%$479.74M$82.06M-6.52460
SMLR
Semler Scientific
2.5886 of 5 stars
$38.95
-3.7%
$71.00
+82.3%
+21.4%$451.08M$56.29M-14.92120
DCTH
Delcath Systems
2.8917 of 5 stars
$12.24
-3.5%
$24.00
+96.1%
+38.4%$441.94M$37.21M-24.4860
TMCI
Treace Medical Concepts
2.509 of 5 stars
$6.05
-2.1%
$10.16
+67.9%
-30.0%$388.66M$209.36M-7.12250News Coverage
OM
Outset Medical
1.7218 of 5 stars
$20.45
-2.2%
$27.00
+32.0%
-71.4%$370.40M$113.69M-0.70520News Coverage
Analyst Forecast
Gap Down
NPCE
NeuroPace
3.543 of 5 stars
$10.22
-1.6%
$15.50
+51.7%
+21.4%$340.78M$79.91M-12.17170
CLPT
ClearPoint Neuro
1.8226 of 5 stars
$11.80
+0.9%
$25.00
+111.9%
+48.3%$327.47M$31.39M-15.53110
NNOX
Nano-X Imaging
2.5752 of 5 stars
$5.12
-3.8%
$9.50
+85.5%
-44.7%$307.38M$11.28M-5.69190News Coverage
Positive News
Analyst Upgrade
SKIN
Beauty Health
0.2829 of 5 stars
$2.20
-3.5%
$1.42
-35.6%
-22.3%$287.27M$334.30M-5.371,030Positive News

Related Companies and Tools


This page (NASDAQ:PTHL) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners